Takahashi, K., Ishibashi, E., Kubo, T., Harada, Y., Hayashi, H., Kano, M., . . . Ikeda, S. (2020). A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial). Medicine (Baltimore), 99(32), e21457. https://doi.org/10.1097/MD.0000000000021457
Chicago Style (17th ed.) CitationTakahashi, Kenta, et al. "A Phase 2 Basket Trial of Combination Therapy with Trastuzumab and Pertuzumab in Patients with Solid Cancers Harboring Human Epidermal Growth Factor Receptor 2 Amplification (JUPITER Trial)." Medicine (Baltimore) 99, no. 32 (2020): e21457. https://doi.org/10.1097/MD.0000000000021457.
MLA (9th ed.) CitationTakahashi, Kenta, et al. "A Phase 2 Basket Trial of Combination Therapy with Trastuzumab and Pertuzumab in Patients with Solid Cancers Harboring Human Epidermal Growth Factor Receptor 2 Amplification (JUPITER Trial)." Medicine (Baltimore), vol. 99, no. 32, 2020, p. e21457, https://doi.org/10.1097/MD.0000000000021457.